CD147 augmented monocarboxylate transporter-1/4 expression through modulation of the Akt-FoxO3-NF-κB pathway promotes cholangiocarcinoma migration and invasion.
Paweena DanaSaowaluk SaisomboonRyusho KariyaSeiji OkadaSumalee ObchoeiKanlayanee SawanyawisuthChaisiri WongkhamChawalit PairojkulSopit WongkhamKulthida VaeteewoottacharnPublished in: Cellular oncology (Dordrecht) (2019)
Our data indicate that CD147 promotes the malignant progression of CCA cells by activating the Akt-FoxO3-NF-κB-MCT-1/4 axis. As such, CD147 may serve as a possible target for advanced CCA treatment.